Published in Ann Intern Med on March 15, 1990
Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis (2011) 4.09
Management of occlusion and thrombosis associated with long-term indwelling central venous catheters. Lancet (2009) 2.37
Low-dose aspirin for the prevention of venous thromboembolism in breast cancer patients treated with infusional chemotherapy after insertion of central vein catheter. Support Care Cancer (2007) 1.42
Venous thromboembolic disease and cancer. Postgrad Med J (2006) 1.23
Catheter tip position as a risk factor for thrombosis associated with the use of subcutaneous infusion ports. Support Care Cancer (2004) 1.23
Thrombosis associated with right internal jugular central venous catheters: A prospective observational study. Indian J Crit Care Med (2012) 1.13
Safety and effectiveness of central venous catheterization in patients with cancer: prospective observational study. J Korean Med Sci (2010) 1.12
Upper extremity deep vein thrombosis: a community-based perspective. Am J Med (2007) 1.11
Internal jugular vein thrombosis presenting as a painful neck mass due to a spontaneous dislocated subclavian port catheter as long-term complication: a case report. Cases J (2009) 1.08
Risk factors for catheter-related thrombosis (CRT) in cancer patients: a patient-level data (IPD) meta-analysis of clinical trials and prospective studies. J Thromb Haemost (2011) 1.05
Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature. Br J Cancer (2004) 1.02
Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications. Thorax (1998) 1.02
Peripherally inserted central venous catheters are not superior to central venous catheters in the acute care of surgical patients on the ward. World J Surg (2006) 1.01
A phase II study of continuous-infusion 5-fluorouracil with cisplatin and epirubicin in inoperable pancreatic cancer. Br J Cancer (1996) 0.99
Thrombosis and cancer. Nat Rev Clin Oncol (2012) 0.88
Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients--a double-blind, randomised, prospective, controlled trial. Support Care Cancer (2005) 0.88
Predictors of venous thromboembolic events associated with central venous port insertion in cancer patients. J Oncol (2014) 0.87
High incidence of occult femoral vein thrombosis related to multiple venous sheaths during electrophysiological studies. Heart (2004) 0.86
Risk-assessment algorithm and recommendations for venous thromboembolism prophylaxis in medical patients. Vasc Health Risk Manag (2007) 0.86
Totally Implantable Venous Access Devices in Children Requiring Long-Term Chemotherapy: Analysis of Outcome in 122 Children from a Single Institution. Indian J Surg Oncol (2016) 0.86
Modified de Gramont with oxaliplatin in the first-line treatment of advanced colorectal cancer. Br J Cancer (2003) 0.85
Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer. Br J Cancer (1998) 0.84
Primary thromboprophylaxis for cancer patients with central venous catheters--a reappraisal of the evidence. Br J Cancer (2006) 0.81
Retrospective cohort analysis comparing the incidence of deep vein thromboses between peripherally-inserted and long-term skin tunneled venous catheters in hemato-oncology patients. Thromb J (2015) 0.81
Diagnosis and management of deep vein thrombosis of the upper extremity: a review. Eur Radiol (2004) 0.81
Minimizing hemodialysis catheter dysfunction: an ounce of prevention. Int J Nephrol (2012) 0.81
Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment. Rev Urol (2010) 0.79
Venous thromboembolism in the cancer population: pathology, risk, and prevention. J Adv Pract Oncol (2012) 0.79
Adverse Interaction between Capecitabine and Warfarin Resulting in Altered Coagulation Parameters: A Review of the Literature Starting from a Case Report. Case Rep Med (2010) 0.78
Prevention of venous thrombosis with minidose warfarin after joint replacement. BMJ (1991) 0.78
Liver regional continuous chemotherapy: use of femoral or subclavian artery for percutaneous implantation of catheter-port systems. World J Gastroenterol (2004) 0.77
Effectiveness of aspirin on double lumen permanent catheter efficacy in ESRD. Nephrourol Mon (2013) 0.77
Pulmonary embolism in parenteral nutrition. Arch Dis Child (1996) 0.77
Second Copenhagen Atrial Fibrillation, Aspirin, and Anticoagulant Therapy Study (AFASAK 2): Methods and Design. J Thromb Thrombolysis (1995) 0.76
Access technique and its problems in parenteral nutrition - Guidelines on Parenteral Nutrition, Chapter 9. Ger Med Sci (2009) 0.75
Management of cancer-associated venous thrombosis. Vasc Health Risk Manag (2006) 0.75
Thrombosis as a complication of central venous access in pediatric patients with malignancies: a 5-year single-center experience. BMC Hematol (2014) 0.75
Medical management of tumor lysis syndrome, postprocedural pain, and venous thromboembolism following interventional radiology procedures. Semin Intervent Radiol (2015) 0.75
Low dose compared to variable dose Warfarin and to Fondaparinux as prophylaxis for thromboembolism after elective hip or knee replacement surgery; a randomized, prospective study. Thromb J (2015) 0.75
Inappropriate preinjury warfarin use in trauma patients: A call for a safety initiative. J Postgrad Med (2016) 0.75
Advances and directions in chemotherapy using implantable port systems for colorectal cancer: a historical review. Surg Today (2013) 0.75
Artificial nutrition support in intestinal failure: principles and practice of parenteral feeding. Clin Colon Rectal Surg (2004) 0.75
Central venous catheter-related thrombosis in cancer patients: what we know and what we need to know. Support Care Cancer (2008) 0.75
Thrombectomy reduces the systemic complications in device-related right atrial septic thrombosis. Can J Cardiol (2009) 0.75
Long-term, low-intensity warfarin after idiopathic venous thromboembolism. CMAJ (2003) 0.75
Clinical pearls in thrombosis and anticoagulation. Mayo Clin Proc (2009) 0.75
Superior vena cava thrombosis and paradoxical embolic stroke due to collateral drainage from the brachiocephalic vein to the left atrium. Tex Heart Inst J (2011) 0.75
Prophylaxis of catheter-related venous thrombosis in cancer patients. Support Care Cancer (2008) 0.75
Specific topics and complications of parenteral nutrition. Langenbecks Arch Surg (2007) 0.75
Endovascular stenting for the management of port-a-cath associated superior vena cava syndrome. Emerg Radiol (2008) 0.75
Catheter-related thrombosis: A practical approach. J Intensive Care Soc (2015) 0.75
Spliced segments at the 5' terminus of adenovirus 2 late mRNA. Proc Natl Acad Sci U S A (1977) 14.34
Formation of mRNA 3' ends in eukaryotes: mechanism, regulation, and interrelationships with other steps in mRNA synthesis. Microbiol Mol Biol Rev (1999) 11.32
Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir. Lancet (2002) 5.48
Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci U S A (1994) 5.00
Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer (2003) 4.22
Integrating primary medical care with addiction treatment: a randomized controlled trial. JAMA (2001) 3.91
c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms. EMBO J (1999) 3.65
Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med (1987) 3.52
The infectivity of adenovirus 5 DNA-protein complex. Virology (1976) 3.12
Thoracic radiotherapy does not prolong survival in patients with locally advanced, unresectable non-small cell lung cancer. Ann Intern Med (1990) 2.64
Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples. Arch Gen Psychiatry (1992) 2.60
Mitochondrial DNA in yeast and some mammalian species. Science (1966) 2.53
Evidence for extraterrestrial amino-acids and hydrocarbons in the Murchison meteorite. Nature (1970) 2.41
Postoperative fluid overload: not a benign problem. Crit Care Med (1990) 2.35
The trouble with cognitive subtraction. Neuroimage (1996) 2.35
Separation of factors required for cleavage and polyadenylation of yeast pre-mRNA. Mol Cell Biol (1992) 2.34
Protection against gram-negative bacteremia and endotoxemia with human monoclonal IgM antibodies. Proc Natl Acad Sci U S A (1985) 2.26
Implantable central venous access system. Am J Surg (1984) 2.23
Screening blood donations for HCV. Lancet (1992) 2.17
Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol (2004) 2.16
Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome. Ann Intern Med (1984) 2.10
Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastases. Arch Surg (1992) 2.10
Surgical margin in hepatic resection for colorectal metastasis: a critical and improvable determinant of outcome. Ann Surg (1998) 2.10
Pretransplant IgG reactivity to apoptotic cells correlates with late kidney allograft loss. Am J Transplant (2014) 2.09
Attachment and adolescent psychosocial functioning. Child Dev (1998) 2.07
Treatment of patients with cancer of an unknown primary site. N Engl J Med (1993) 2.00
Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation. J Clin Oncol (1997) 1.97
Acute vascular ischemic events after cisplatin-based combination chemotherapy for germ-cell tumors of the testis. Ann Intern Med (1986) 1.90
The origins of joint visual attention in infants. Dev Psychol (1998) 1.85
Cancers of unknown primary site: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2011) 1.84
Small cell lung cancer. Complete remission and improved survival. Am J Med (1979) 1.83
Complications and management of implanted venous access catheters. J Clin Oncol (1985) 1.82
Valgus knee stress in lumbosacral myelomeningocele: a gait-analysis evaluation. J Pediatr Orthop (1998) 1.81
Targets and cues: gaze-following in children with autism. J Child Psychol Psychiatry (1998) 1.79
Continued emergence and changing epidemiology of oseltamivir-resistant influenza A(H1N1)2009 virus, United Kingdom, winter 2010/11. Euro Surveill (2011) 1.76
Nonsurgical factors that influence the outcome of bariatric surgery: a review. Psychosom Med (1998) 1.76
Carcinoembryonic antigen: clinical correlation with chemotherapy for metastatic gastrointestinal cancer. Cancer (1974) 1.74
Low incidence of non-A, non-B post-transfusion hepatitis in London confirmed by hepatitis C virus serology. Lancet (1991) 1.71
Longitudinal changes of structural connectivity in traumatic axonal injury. Neurology (2011) 1.68
Five subunits are required for reconstitution of the cleavage and polyadenylation activities of Saccharomyces cerevisiae cleavage factor I. Proc Natl Acad Sci U S A (2001) 1.68
The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer. J Clin Oncol (1986) 1.67
Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial. Cancer J Sci Am (1999) 1.67
Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease. Proc Natl Acad Sci U S A (1982) 1.64
Carcinoma of unknown primary site: treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide. J Clin Oncol (1997) 1.62
Association of outpatient alcohol and drug treatment with health care utilization and cost: revisiting the offset hypothesis. J Stud Alcohol (2001) 1.61
Attention and joint attention in preschool children with autism. Dev Psychol (2000) 1.59
Pta1, a component of yeast CF II, is required for both cleavage and poly(A) addition of mRNA precursor. Mol Cell Biol (1999) 1.59
The outcome and cost of alcohol and drug treatment in an HMO: day hospital versus traditional outpatient regimens. Health Serv Res (2000) 1.57
A family practice perspective on health care for the elderly. CMAJ (1987) 1.55
White-tailed deer as a potential reservoir of Ehrlichia spp. J Wildl Dis (1994) 1.53
Weekly docetaxel in the treatment of elderly patients with advanced breast cancer: a Minnie Pearl Cancer Research Network phase II trial. J Clin Oncol (2001) 1.52
Processivity of the Saccharomyces cerevisiae poly(A) polymerase requires interactions at the carboxyl-terminal RNA binding domain. Mol Cell Biol (1998) 1.51
Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group. J Clin Oncol (1993) 1.51
Photodynamic treatment of herpes keratitis. Infect Immun (1972) 1.51
Low-dose methotrexate therapy for childhood sarcoidosis. J Pediatr (1997) 1.51
Ultrasonography by emergency physicians in patients with suspected cholecystitis. Am J Emerg Med (2001) 1.50
Open study of the catechol-O-methyltransferase inhibitor tolcapone in major depressive disorder. J Clin Psychopharmacol (1999) 1.50
Dose-intensive melphalan with blood stem-cell support for the treatment of AL (amyloid light-chain) amyloidosis: survival and responses in 25 patients. Blood (1998) 1.48
Influence of age on the response to Streptococcus pneumoniae vaccine in patients with recurrent infections and normal immunoglobulin concentrations. J Allergy Clin Immunol (1998) 1.48
Multi-day fractionated administration schedule for paclitaxel. Ann Oncol (1995) 1.48
A human vascular disorder, supravalvular aortic stenosis, maps to chromosome 7. Proc Natl Acad Sci U S A (1993) 1.48
Albumin supplementation in the critically ill. A prospective, randomized trial. Arch Surg (1990) 1.47
Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity. Ann Intern Med (1988) 1.47
Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun (2005) 1.47
Rituximab monoclonal antibody as initial systemic therapy for patients with low-grade non-Hodgkin lymphoma. Blood (2000) 1.47
Phase I trial of docetaxel administered by weekly infusion in patients with advanced refractory cancer. J Clin Oncol (1998) 1.46
Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol. J Clin Oncol (1989) 1.46
High-dose cisplatin combination chemotherapy in the treatment of advanced epithelial ovarian carcinoma. J Clin Oncol (1990) 1.46
Interstitial deletion of (17)(p11.2p11.2): report of six additional patients with a new chromosome deletion syndrome. Am J Med Genet (1986) 1.44
Paclitaxel administered by a 1-hour infusion: A phase I-II trial comparing two schedules. Cancer J Sci Am (2006) 1.44
Low effectiveness of seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2014/15 mid-season results. Euro Surveill (2015) 1.44
Etoposide kinetics in patients with obstructive jaundice. J Clin Oncol (1990) 1.43
Mobilized CD34+ cells selected as autografts in patients with primary light-chain amyloidosis: rationale and application. Transfusion (1998) 1.42
Surgical treatment of necrotizing pancreatitis by necrosectomy and closed lavage: changing patient characteristics and outcome in a 19-year, single-center series. Surgery (2005) 1.41
Need for a patient advocate. JAMA (1989) 1.39
Selectivity, scope, and simplicity of models: a lesson from fitting judgments of perceived depth. J Exp Psychol Gen (1992) 1.39
The risks of surgery in obese patients. Ann Intern Med (1986) 1.38
Acute-phase proteins or tumour markers: the role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases. Scand J Immunol (1984) 1.38
Current concepts in cancer: small-cell lung cancer. N Engl J Med (1979) 1.37
Phosphorescence depolarization and the measurement of rotational motion of proteins in membranes. FEBS Lett (1979) 1.35
Advanced poorly differentiated carcinoma of unknown primary site: recognition of a treatable syndrome. Ann Intern Med (1986) 1.32
Vaccine effectiveness of 2011/12 trivalent seasonal influenza vaccine in preventing laboratory-confirmed influenza in primary care in the United Kingdom: evidence of waning intra-seasonal protection. Euro Surveill (2013) 1.32
Prognostic factors for favorable outcome in disseminated germ cell tumors. J Clin Oncol (1986) 1.31
Factors affecting the initiation of substance abuse treatment in managed care. Addiction (2001) 1.30
A QTL on chromosome 6A in bread wheat (Triticum aestivum) is associated with longer coleoptiles, greater seedling vigour and final plant height. Theor Appl Genet (2007) 1.30
Metastatic breast cancer confined to the skeletal system. An indolent disease. Am J Med (1986) 1.28
Combined small-cell and non-small-cell lung cancer. J Clin Oncol (1989) 1.26
Small-cell lung cancer. A curable disease. Cancer Chemother Pharmacol (1980) 1.24
Health effects of exposure to cyanobacteria (blue-green algae) during recreational water-related activities. Aust N Z J Public Health (1997) 1.24
Constitutively active MuSK is clustered in the absence of agrin and induces ectopic postsynaptic-like membranes in skeletal muscle fibers. J Neurosci (1999) 1.23
Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator. Blood (1988) 1.22
Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol. J Clin Oncol (1991) 1.22
The role of maintenance therapy in disseminated testicular cancer. N Engl J Med (1981) 1.22
Chronic daily administration of oral etoposide--a phase I trial. J Clin Oncol (1989) 1.20